Wolverine Asset Management LLC Theravance Biopharma, Inc. Transaction History
Wolverine Asset Management LLC
- $5.25 Billion
- Q2 2025
A detailed history of Wolverine Asset Management LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 65,800 shares of TBPH stock, worth $948,178. This represents 0.02% of its overall portfolio holdings.
Number of Shares
65,800Holding current value
$948,178% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TBPH
# of Institutions
138Shares Held
48.1MCall Options Held
0Put Options Held
11.6K-
Madison Avenue Partners, LP New York, NY9.51MShares$137 Million11.23% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$107 Million1.24% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$71.3 Million10.56% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$54.5 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$39.8 Million4.49% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $962M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...